EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA-Based Strategies for Cancer Therapy: In Silico Design and Evaluation of ASOs for Targeted Exon Skipping

Chiara Pacelli iD, Alice Rossi, Michele Milella iD, Teresa Colombo iD, Loredana Le Pera iD

International Journal of Molecular Sciences · 03.10.2023 · 24 (19) · 14862

DOI: 10.3390/ijms241914862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.10.2023. Verfasst von Chiara Pacelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision medicine in oncology has made significant progress in recent years by approving drugs that target specific genetic mutations. However, many cancer driver genes remain challenging to pharmacologically target (“undruggable”). To tackle this issue, RNA-based methods like antisense oligonucleotides (ASOs) that induce targeted exon skipping (ES) could provide a promising alternative. In this work, a comprehensive computational procedure is presented, focused on the development of ES-based cancer treatments. The procedure aims to produce specific protein variants, including inactive oncogenes and partially restored tumor suppressors. This novel computational procedure encompasses target-exon selection, in silico prediction of ES products, and identification of the best candidate ASOs for further experimental validation. The method was effectively employed on extensively mutated cancer genes, prioritized according to their suitability for ES-based interventions. Notable genes, such as NRAS and VHL, exhibited potential for this therapeutic approach, as specific target exons were identified and optimal ASO sequences were devised to induce their skipping. To the best of our knowledge, this is the first computational procedure that encompasses all necessary steps for designing ASO sequences tailored for targeted ES, contributing with a versatile and innovative approach to addressing the challenges posed by undruggable cancer driver genes and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligonucleotides, AntisenseNeoplasmsHumansRNARNA SplicingExons

Stichwörter der Autor:innen

ASORNA therapyantisense oligonucleotidebioinformaticscancersplicingtargeted exon skipping

Substanzen

Oligonucleotides, AntisenseRNA

Autor:innen und Institutionen

  • Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy.
  • Section of Oncology, Department of Medicine, University of Verona-School of Medicine and Verona University Hospital Trust, 37134 Verona, Italy.
  • Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), 00185 Rome, Italy.
  • Core Facilities, Italian National Institute of Health (ISS), 00161 Rome, Italy.

ORCID-Profile: Chiara Pacelli, Michele Milella, Teresa Colombo, Loredana Le Pera

Zitieren

APA

Pacelli, C., Rossi, A., Milella, M., Colombo, T., & Le Pera, L. (2023). RNA-Based Strategies for Cancer Therapy: In Silico Design and Evaluation of ASOs for Targeted Exon Skipping. International Journal of Molecular Sciences, 24(19), 14862. https://doi.org/10.3390/ijms241914862

Vancouver

Pacelli C, Rossi A, Milella M, Colombo T, Le Pera L. RNA-Based Strategies for Cancer Therapy: In Silico Design and Evaluation of ASOs for Targeted Exon Skipping. International Journal of Molecular Sciences. 2023;24(19):14862. doi:10.3390/ijms241914862

BibTeX
@article{Pacelli2023,
  author = {Pacelli, Chiara and Rossi, Alice and Milella, Michele and Colombo, Teresa and Le Pera, Loredana},
  title = {RNA-Based Strategies for Cancer Therapy: In Silico Design and Evaluation of ASOs for Targeted Exon Skipping},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {19},
  pages = {14862},
  doi = {10.3390/ijms241914862}
}
Kostenlos starten →